Lachey Jennifer

CIK 00018083221 companyLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808322

Recent Transactions

50 trades

Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-07-15−46,034→ 8,755 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-07-15$0.30/sh+46,034→ 141,134 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-07-15$30.00/sh−46,034→ 95,100 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-07-13−1,916→ 54,789 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-07-13$30.00/sh−1,916→ 95,100 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-07-13$0.30/sh+1,916→ 93,184 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-06-14$0.30/sh+9,400→ 95,100 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-06-14−9,400→ 56,705 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$41.26/sh−3,398→ 87,602 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-05-11−5,300→ 66,105 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$45.45/sh−16→ 85,700 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$43.32/sh−719→ 85,939 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$42.49/sh−944→ 86,658 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$0.30/sh+5,300→ 91,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-05-11$44.23/sh−223→ 85,716 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-11$63.50/sh−2,315→ 86,259 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-11$0.30/sh+5,300→ 91,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-11$61.37/sh−1,417→ 89,583 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-11$64.15/sh−559→ 85,700 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-11$62.32/sh−1,009→ 88,574 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-04-11−5,300→ 71,405 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
of Shares Employee Stock Option (right to buy)
2022-04-04−7,950→ 76,705 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-04$60.00/sh−7,950→ 85,700 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-04-04$0.30/sh+7,950→ 93,650 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-03-11$52.43/sh−1,062→ 87,288 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-03-11$0.30/sh+2,650→ 88,350 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-03-11$53.36/sh−713→ 86,575 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-03-11−2,650→ 84,655 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-03-11$54.54/sh−875→ 85,700 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-02-11$52.35/sh−1,378→ 85,899 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-02-11$0.30/sh+2,650→ 88,350 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-02-11$53.10/sh−199→ 85,700 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-02-11$51.50/sh−1,073→ 87,277 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-02-11−2,650→ 87,305 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-01-21+50,000→ 50,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-01-11−2,650→ 89,955 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-11$53.56/sh−1,196→ 86,834 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-11$54.45/sh−1,134→ 85,700 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-11$52.01/sh−320→ 88,030 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-11$0.30/sh+2,650→ 88,350 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$60.00/sh−2,650→ 85,700 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$0.30/sh+2,650→ 88,350 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-01-05−2,650→ 92,605 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-12-15−735→ 95,255 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-15$50.00/sh−735→ 85,700 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-15$0.30/sh+735→ 86,435 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-12-13−1,915→ 95,990 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-13$50.11/sh−1,518→ 86,097 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-13$53.64/sh−7→ 85,700 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-13$0.30/sh+1,915→ 87,615 total

Companies

Keros Therapeutics, Inc.
Chief Scientific Officer
$KROS

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 99 HAYDEN AVENUE, SUITE 120, BUILDING E

LEXINGTON, MA, 02421

View on SEC.gov